Ogorek Anthony Joseph Amarin Corp Plcuk Transaction History

Ogorek Anthony Joseph

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$0.82 - $1.35 $2,255 - $3,712	2,750 New	2,750 $2,000
Q1 2023 May 03, 2023	BUY	$1.19 - $2.19 $3,272 - $6,022	2,750 New	2,750 $4,000
Q2 2022 Jul 21, 2022	SELL	$1.13 - $3.69 $11,695 - $38,191	-10,350 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$3.24 - $5.18 $38,232 - $61,124	-11,800 Reduced 53.27%	10,350 $34,000
Q3 2021 Oct 27, 2021	BUY	$3.94 - $5.84 $40,779 - $60,444	10,350 Added 87.71%	22,150 $112,000
Q4 2020 Jan 20, 2021	SELL	$4.04 - $5.31 $41,814 - $54,958	-10,350 Reduced 46.73%	11,800 $44,000
Q3 2020 Nov 02, 2020	BUY	$3.64 - $7.76 $3,094 - $6,596	850 Added 3.99%	22,150 $93,000
Q1 2020 Apr 10, 2020	BUY	$4.0 - $21.53 $4,200 - $22,606	1,050 Added 5.19%	21,300 $85,000
Q4 2019 Jan 21, 2020	BUY	$13.94 - $24.12 $4,042 - $6,994	290 Added 1.45%	20,250 $434,000
Q3 2019 Oct 17, 2019	BUY	$13.89 - $23.16 $30,002 - $50,025	2,160 Added 12.13%	19,960 $302,000
Q2 2019 Jul 15, 2019	BUY	$16.27 - $20.51 $90,298 - $113,830	5,550 Added 45.31%	17,800 $345,000
Q4 2018 Jan 08, 2019	BUY	$12.41 - $22.98 $152,022 - $281,505	12,250 New	12,250 $166,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

Stay updated on Ogorek Anthony Joseph with notifications on news.